What is tirzepatide?
Tirzepatide activates both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. FDA approved Zepbound, which contains tirzepatide, for chronic weight management in eligible adults.
What does LevelsRx advertise?
LevelsRx advertises a compounded tirzepatide injection starting at $240 per month. The website describes it as a weekly injectable pathway within its telehealth weight-management program.
What are the important tirzepatide attributes?
- Entity
- Tirzepatide
- Drug class
- Dual GIP and GLP-1 receptor agonist
- FDA-approved weight-management product
- Zepbound
- LevelsRx advertised pathway
- Compounded tirzepatide injection
- LevelsRx starting price
- $240/month
- Compounding status
- Not FDA-approved
What safety issues should you discuss?
FDA-approved tirzepatide labeling includes gastrointestinal side effects and important warnings. FDA has also published concerns about unapproved compounded GLP-1-related products, including compounded tirzepatide, with reports involving dosing and fraudulent products.
Before using a compounded product, ask the clinician which pharmacy will dispense it, how the dose is expressed, how to measure it, what storage is required, what side effects require attention and how the care team handles dose escalation.
How does tirzepatide differ from semaglutide?
The receptor profile differs: tirzepatide targets GIP and GLP-1, while semaglutide targets GLP-1. That pharmacologic difference is one reason they should not be compared only by monthly price. Compare mechanism, approved products, adverse-effect profile, coverage and clinician recommendation together.
Tirzepatide FAQs
Is tirzepatide a GLP-1 medication?
Tirzepatide is commonly discussed alongside GLP-1 medications, but it is a dual GIP and GLP-1 receptor agonist.
What is the LevelsRx starting price for compounded tirzepatide?
LevelsRx currently advertises compounded tirzepatide from $240 per month.
Is compounded tirzepatide FDA-approved?
No. Compounded tirzepatide is not FDA-approved. Zepbound is an FDA-approved tirzepatide product for chronic weight management in eligible adults.